This week we highlight a new diagnostic device for detecting traumatic brain injury and the U.S. Food and Drug Administration’s investigation into the risk of patients developing new cancers after receiving CAR-T cell immunotherapies. We also look at a new generative artificial intelligence biotech ... READ MORE >
Life sciences
This week’s 5 things to know in life sciences
This week we highlight the challenges related to hepatitis B treatments and the U.S. Food and Drug Administration’s advisory committee meeting regarding timely accelerated approval confirmations. We also look at a new study that highlights COVID-19 rebounds and the exodus of life sciences researchers from ... READ MORE >
5 things to know in life sciences this week
This week we highlight the emergence of Denmark as a major life sciences hub in Europe and the impact of technology on patients, as well as awareness-building on clinical trials. We also look at growth of the life sciences industry in Utah and new legislation in Europe that some say will decrease ... READ MORE >
5 things to know in life sciences: Week of Oct. 30, 2023
This week, we highlight the potential U.S. ban on Apple Watches over patent infringement as well as an analysis of biopharma market cap as it relates to the new U.S. drug price negotiations. We also look at the White House's new artificial intelligence directive aimed to ensure ethical biotech ... READ MORE >
5 things to know in life sciences: Week of Oct. 23, 2023
This week, we highlight Minnesota’s designation as a medtech hub, new developments in medtech in the UK and increased licensing deals in the biopharma sector. Additionally, we spotlight a positive outlook for next year in the life sciences services sector. Lastly, we continue to look at the importance of ... READ MORE >
5 things to know in life sciences: Week of Oct. 16, 2023
This week we delve into the pharmaceutical industry’s reputation among neurology patient groups. Also, the biopharma industry continues to make substantial investments in mergers and acquisitions, and Korean contract development and manufacturing organizations struggle to meet the needs of the cell and ... READ MORE >
5 things to know in life sciences: Week of Oct. 9, 2023
This week, we delve into Bristol Myers Squibb's significant acquisition of Mirati Therapeutics. Also, we look at the U.S. Food and Drug Administration’s formation of a digital health advisory committee and the groundbreaking approval of a genetic test for cancer risk assessment. Additionally, we spotlight ... READ MORE >
5 things to know in life sciences: Week of Oct. 2, 2023
This week we explore a significant financing for an artificial intelligence-based biotech company, an investment in medtech by the UK government and a U.S. Food and Drug Administration visit to a major medtech incubator. We also look at a new product using AI to provide information regarding clinical ... READ MORE >
5 things to know in life sciences: Week of Sept. 25, 2023
This week we explore the development of a drug to grow teeth and the start of clinical trials for rabies vaccines. We also look at the labor shortage in biopharma manufacturing and Medicare’s solvency concerns. In addition, we highlight a survey which shows that artificial intelligence is the top area for ... READ MORE >
5 things to know in life sciences: Week of Sept. 18, 2023
This week we explore the Food and Drug Administration’s new guidance related to single trial approvals and the National Institutes of Health’s commencement of a trial for a universal flu vaccine. We also look at the start of clinical trials for CRISPR-based leukemia treatment and the FDA’s rejection of a ... READ MORE >